Domenico Mallardo1, Mario Fordellone2, Michael Bailey3

  • 1Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.

概括

预测性基因表达特征可以在针对黑色素瘤的抗PD-1治疗期间识别患有免疫相关不良事件 (irAEs) 高风险的患者. 这允许个性化毒性监测和改善患者管理.